Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04190186 · ClinicalTrials.gov registry record · NA
Hybrid Ablation Plus Medical Therapy for Persistent Atrial Fibrillation
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT04190186 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 55 participants.
The verdict
NCT04190186, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
This clinical trial is designed to compare two management strategies for the treatment of asymptomatic/subclinical atrial fibrillation after ablation based on data from the Biotronik ICM (BioMonitor3® or future generation of Biotronik ICM).
Interventions
- DEVICE Insertable Cardiac Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2020-06-25 |
| Est. Completion | 2024-02-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04190186
The ClinicalTrials.gov registry entry for NCT04190186 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Insertable Cardiac Monitor is the first listed.
NCT04190186 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04190186 about?
NCT04190186 is a clinical study titled "Hybrid Ablation Plus Medical Therapy for Persistent Atrial Fibrillation". This clinical trial is designed to compare two management strategies for the treatment of asymptomatic/subclinical atrial fibrillation after ablation based on data from the Biotronik ICM (BioMonitor3® or future generation of Biotronik ICM).
What is the current status of trial NCT04190186?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2020-06-25. Estimated completion is 2024-02-15.
What interventions are being tested in trial NCT04190186?
The interventions under investigation include: Insertable Cardiac Monitor (DEVICE).
Who is sponsoring clinical trial NCT04190186?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.